Cardiovascular disease and cardiovascular outcomes in COVID-19

被引:6
作者
Fisher, Miles [1 ]
机构
[1] Glasgow Royal Infirm, Glasgow, Lanark, Scotland
关键词
coronavirus; COVID-19; cardiovascular disease; troponin; myocarditis; heart failure; arrhythmia; SYSTEM;
D O I
10.1002/pdi.2294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with cardiovascular disease have an increased risk of severe COVID-19 disease and an increased mortality. Clinical observations have described cardiovascular complications of COVID-19 in patients without prior cardiovascular disease, including acute cardiac injury, myocarditis, heart failure, arrhythmias, and acute coronary syndromes. These are also associated with a worse outcome from COVID-19. Several of the potential treatments for COVID-19 may also have cardiovascular consequences. Some of the acute cardiovascular complications resolve on recovery from the infection and it is uncertain how many people will suffer permanent cardiovascular damage. During the emergency lockdown that was introduced to deal with the pandemic it has been observed that hospital admissions with other cardiovascular conditions, such as acute coronary syndromes and heart failure, have been greatly reduced. Copyright (c) 2020 John Wiley & Sons.
引用
收藏
页码:191 / +
页数:4
相关论文
共 23 条
  • [1] Barron E, 2020, TYPE 1 TYPE 2 DIABET
  • [2] COVID-19 and cardiac arrhythmias
    Bhatla, Anjali
    Mayer, Michael M.
    Adusumalli, Srinath
    Hyman, Matthew C.
    Oh, Eric
    Tierney, Ann
    Moss, Juwann
    Chahal, Anwar A.
    Anesi, George
    Denduluri, Srinivas
    Domenico, Christopher M.
    Arkles, Jeffrey
    Abella, Benjamin S.
    Bullinga, John R.
    Callans, David J.
    Dixit, Sanjay
    Epstein, Andrew E.
    Frankel, David S.
    Garcia, Fermin C.
    Kumareswaram, Ramanan
    Nazarian, Saman
    Riley, Michael P.
    Santangeli, Pasquale
    Schaller, Robert D.
    Supple, Gregory E.
    Lin, David
    Marchlinski, Francis
    Deo, Rajat
    [J]. HEART RHYTHM, 2020, 17 (09) : 1439 - 1444
  • [3] Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
    de Abajo, Francisco J.
    Rodriguez-Martin, Sara
    Lerma, Victoria
    Mejia-Abril, Gina
    Aguilar, Monica
    Garcia-Luque, Amelia
    Laredo, Leonor
    Laosa, Olga
    Centeno-Soto, Gustavo A.
    Galvez, Maria Angeles
    Puerro, Miguel
    Gonzalez-Rojano, Esperanza
    Pedraza, Laura
    de Pablo, Itziar
    Abad-Santos, Francisco
    Rodriguez-Manas, Leocadio
    Gil, Miguel
    Tobias, Aurelio
    Rodriguez-Miguel, Antonio
    Rodriguez-Puyol, Diego
    [J]. LANCET, 2020, 395 (10238) : 1705 - 1714
  • [4] De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166
  • [5] Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
    Driggin, Elissa
    Madhavan, Mahesh V.
    Bikdeli, Behnood
    Chuich, Taylor
    Laracy, Justin
    Biondi-Zoccai, Giuseppe
    Brown, Tyler S.
    Nigoghossian, Caroline Der
    Zidar, David A.
    Haythe, Jennifer
    Brodie, Daniel
    Beckman, Joshua A.
    Kirtane, Ajay J.
    Stone, Gregg W.
    Krumholz, Harlan M.
    Parikh, Sahil A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (18) : 2352 - 2371
  • [6] Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
    Esler, Murray
    Esler, Danielle
    [J]. JOURNAL OF HYPERTENSION, 2020, 38 (05) : 781 - 782
  • [7] Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.46234/ccdcw2020.032, 10.3760/cma.j.issn.0254-6450.2020.02.003]
  • [8] Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
    Holman, Naomi
    Knighton, Peter
    Kar, Partha
    O'Keefe, Jackie
    Curley, Matt
    Weaver, Andy
    Barron, Emma
    Bakhai, Chirag
    Khunti, Kamlesh
    Wareham, Nicholas J.
    Sattar, Naveed
    Young, Bob
    Valabhji, Jonathan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10) : 823 - 833
  • [9] Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19
    Jarcho, John A.
    Ingelfinger, Julie R.
    Hamel, Mary Beth
    D'Agostino, Ralph B.
    Harrington, David P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) : 2462 - 2464
  • [10] Cardiac Arrhythmias in COVID-19 Infection
    Kochav, Stephanie M.
    Coromilas, Ellie
    Nalbandian, Ani
    Ranard, Lauren S.
    Gupta, Aakriti
    Chung, Mina K.
    Gopinathannair, Rakesh
    Biviano, Angelo B.
    Garan, Hasan
    Wan, Elaine Y.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2020, 13 (06) : E008719